Maine · 132nd Legislature (2025-2026) · Bill
LD 1687: An Act To Clarify And Increase Access To Hiv Prevention Medications
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
LD 1687 is a bill introduced in the Maine House on April 17, 2025. According to its official title, it concerns: An Act To Clarify And Increase Access To Hiv Prevention Medications. Primary sponsor: Matt Moonen (Democratic). It lists 5 additional sponsors. Most recent recorded action (July 1, 2025): Signed by Governor.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 6
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Matt Moonen | Primary sponsor | Democratic | House | 117 |
| Michelle Boyer | Co-sponsor | Democratic | House | 123 |
| Sally Cluchey | Co-sponsor | Democratic | House | 52 |
| Ryan Fecteau | Co-sponsor | Democratic | House | 132 |
| Anne-Marie Mastraccio | Co-sponsor | Democratic | House | 142 |
| Kristi Mathieson | Co-sponsor | Democratic | House | 151 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Signed by Governor
- PASSED TO BE ENACTED in concurrence.
- On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table
- On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence
- Reported Out - OTP-AM
- Sent for concurrence. ORDERED SENT FORTHWITH.
- PASSED TO BE ENACTED.
- Ordered sent down forthwith.
- Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (H-642), in concurrence.
- Committee Amendment "A" (H-642) READ and ADOPTED, in concurrence.
- READ ONCE.
- Report READ and ACCEPTED, in concurrence.
Showing 12 most recent of 22 actions. Full history